Europe Heparin Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • Europe
  • 350 Pages
  • No of Tables: 268
  • No of Figures: 35

Europe Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), Mode of Administration (Oral Administration, Parenteral  Administration), Source (Bovine, Porcine), Ingredients(Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others),  Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others),  Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others),   Type (Generics, Brands),  Container (Bottles, Bags, Vials, Others),  Packaging (Glass, Plastic),  End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe). – Industry Trends and Forecast to 2026

Heparin is medication is used to prevent and treat blood clots. It is used to treat blood clotting disorders. It is also used to prevent blood clots after surgery, during blood transfusions, dialysis, and blood samples. It helps in smooth blood flowing by releasing anti-clotting protein. It is known as an anticoagulant. It is also used in diagnose and treatment of disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It cannot dissolve blood clots but only prevent the clots from becoming larger and causing more serious problems. Heparin is an animal-derived product, derived from mucosal tissues of slaughtered meat animals.

Heparin is used for Diagnosis of heart attacks and unstable angina, Inhibition of cancer, metabolic disorders, and hepatitis, as an anti-inflammatory drug in injuries as Anti-Coagulants in blood sampling.

Europe heparin market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: Europe Heparin Market

Europe heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, Type, container, packaging, end user, distribution channel. 

  • On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH)
  • On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
  • On the basis of source, the market is segmented into bovine and porcine
  • On the basis of ingredients, the market is segmented into sodium and calcium and others
  • On the basis of availability, the market is segmented into raw, and processed
  • On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
  • On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
  • On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
  • On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
  • On the basis of type, the market is segmented into generics and brands
  • On the basis of container, the market is segmented into bottles, bags, vials and others
  • On the basis of packaging, the market is segmented into glass and plastic
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Competitive Analysis: Europe Heparin Market

Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, OPOCRIN S.P.A, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited, among others.

Recent Developments:

  • In September 2018, SANOFI (France) announced Health Canada’s approval of a new indication for Lovenox (LMWH) for the prevention of thrombus formation in the extra-corporeal circulation during haemodialysis in patients with end stage kidney disease (ESKD). This will attract the potential consumers helping in the growth of the company
  • In August 2018, Fresenius Kabi (Germany) launched four new Heparin Sodium in freeflex containers.  It is advance IV-container technology.  The major advantage of this product launch is to expand the portfolio of convenient, ready-to-administer medicines in non-DEHP bags as well as in prefilled syringes
  • In 2019, Bioiberica's Business Unit participated in DCAT 2019 with the objective of establishing strategic alliances and find new business opportunities in the U.S market. By these conferences the company will grow in the market by developing alliances

Research Methodology: Europe Heparin Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 EUROPE UNFRACTIONATED HEPARIN IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 EUROPE LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 EUROPE LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2016-2026 (USD MILLION)

TABLE 5 EUROPE ULTRA LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 EUROPE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY TYPE, 2016-2026 (USD MILLION)

TABLE 7 EUROPE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 8 EUROPE ORAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 EUROPE PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 10 EUROPE PARENTRAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 12 EUROPE BOVINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 EUROPE PORCINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 EUROPE HEPARIN MARKET, BY INGREDIENTS, 2016-2026 (USD MILLION)

TABLE 15 EUROPE SODIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 EUROPE CALCIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 EUROPE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 19 EUROPE RAW IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 TABLE1 EUROPE PROCESSED IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 22 EUROPE DEEP VEIN THROMBOSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE PULMONARY EMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE ARTERIAL THROMBOEMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE PRE-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE POST-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE KIDNEY DIALYSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE DIAGNOSTIC TEST IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 33 EUROPE CARDIOVASCULAR IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE RESPIRATORY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE ONCOLOGY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 EUROPE NEPHROLOGY IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 37 EUROPE CNS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 EUROPE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 40 EUROPE 10 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 41 EUROPE 100 UNIT IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 42 EUROPE 1000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 43 EUROPE 5000 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 44 EUROPE 10000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 45 EUROPE 25000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 46 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 47 EUROPE GENERICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 48 EUROPE HEPARIN MARKET, BY BRANDED, 2017-2026 (USD MILLION)

TABLE 49 EUROPE BRANDEDS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 50 EUROPE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 51 EUROPE BOTTLES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 52 EUROPE BAGS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 53 EUROPE VIALS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 55 EUROPE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 56 EUROPE GLASS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 57 EUROPE PLASTIC IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 58 EUROPE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 EUROPE HOSPITALS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 60 EUROPE CLINICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 61 EUROPE HOMECARE IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 62 EUROPE AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 63 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 64 EUROPE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 65 EUROPE HOSPITAL PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 66 EUROPE RETAIL PHARMACY & DRUG STORE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 67 EUROPE ONLINE PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 68 EUROPE OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 69 EUROPE HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 70 EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 71 EUROPE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 72 EUROPE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 73 EUROPE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 74 EUROPE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 75 EUROPE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 76 EUROPE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 77 EUROPE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 78 EUROPE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 79 EUROPE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 EUROPE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 81 EUROPE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 82 EUROPE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 83 EUROPE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 84 EUROPE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 85 EUROPE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 86 EUROPE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 87 EUROPE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 88 GERMANY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 89 GERMANY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 90 GERMANY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 91 GERMANY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 92 GERMANY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 93 GERMANY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 94 GERMANY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 95 GERMANY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 96 GERMANY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 97 GERMANY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 98 GERMANY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 99 GERMANY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 100 GERMANY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 101 GERMANY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 102 GERMANY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 103 GERMANY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 104 GERMANY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 105 GERMANY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 106 U.K. HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 107 U.K. LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 108 U.K. ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 109 U.K. HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 110 U.K. PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 111 U.K. HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 112 U.K. HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 113 U.K. HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 114 U.K. HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 115 U.K. HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 U.K. HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 117 U.K. HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 118 U.K. HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 119 U.K. BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 120 U.K. HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 121 U.K. HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 122 U.K. HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 123 U.K. HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 124 FRANCE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 125 FRANCE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 126 FRANCE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 127 FRANCE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 128 FRANCE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 129 FRANCE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 130 FRANCE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 131 FRANCE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 132 FRANCE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 133 FRANCE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 134 FRANCE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 135 FRANCE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 136 FRANCE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 137 FRANCE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 138 FRANCE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 139 FRANCE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 140 FRANCE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 141 FRANCE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 142 SPAIN HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 143 SPAIN LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 144 SPAIN ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 145 SPAIN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 146 SPAIN PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 147 SPAIN HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 148 SPAIN HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 149 SPAIN HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 150 SPAIN HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 151 SPAIN HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 152 SPAIN HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 153 SPAIN HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 154 SPAIN HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 155 SPAIN BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 156 SPAIN HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 157 SPAIN HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 158 SPAIN HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 159 SPAIN HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 160 ITALY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 161 ITALY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 162 ITALY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 163 ITALY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 164 ITALY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 165 ITALY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 166 ITALY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 167 ITALY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 168 ITALY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 169 ITALY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 170 ITALY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 171 ITALY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 172 ITALY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 173 ITALY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 174 ITALY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 175 ITALY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 176 ITALY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 177 ITALY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 178 RUSSIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 179 RUSSIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 180 RUSSIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 181 RUSSIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 182 RUSSIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 183 RUSSIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 184 RUSSIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 185 RUSSIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 186 RUSSIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 187 RUSSIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 188 RUSSIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 189 RUSSIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 190 RUSSIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 191 RUSSIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 192 RUSSIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 193 RUSSIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 194 RUSSIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 195 RUSSIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 196 SWITZERLAND HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 197 SWITZERLAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 198 SWITZERLAND ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 199 SWITZERLAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 200 SWITZERLAND PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 201 SWITZERLAND HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 202 SWITZERLAND HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 203 SWITZERLAND HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 204 SWITZERLAND HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 205 SWITZERLAND HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 206 SWITZERLAND HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 207 SWITZERLAND HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 208 SWITZERLAND HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 209 SWITZERLAND BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 210 SWITZERLAND HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 211 SWITZERLAND HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 212 SWITZERLAND HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 213 SWITZERLAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 214 NETHERLANDS HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 215 NETHERLANDS LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 216 NETHERLANDS ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 217 NETHERLANDS HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 218 NETHERLANDS PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 219 NETHERLANDS HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 220 NETHERLANDS HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 221 NETHERLANDS HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 222 NETHERLANDS HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 223 NETHERLANDS HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 224 NETHERLANDS HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 225 NETHERLANDS HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 226 NETHERLANDS HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 227 NETHERLANDS BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 228 NETHERLANDS HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 229 NETHERLANDS HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 230 NETHERLANDS HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 231 NETHERLANDS HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 232 TURKEY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 233 TURKEY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 234 TURKEY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 235 TURKEY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 236 TURKEY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 237 TURKEY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 238 TURKEY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 239 TURKEY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 240 TURKEY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 241 TURKEY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 242 TURKEY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 243 TURKEY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 244 TURKEY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 245 TURKEY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 246 TURKEY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 247 TURKEY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 248 TURKEY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 249 TURKEY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 250 BELGIUM HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 251 BELGIUM LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 252 BELGIUM ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 253 BELGIUM HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 254 BELGIUM PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 255 BELGIUM HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 256 BELGIUM HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 257 BELGIUM HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 258 BELGIUM HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 259 BELGIUM HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 260 BELGIUM HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 261 BELGIUM HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 262 BELGIUM HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 263 BELGIUM BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 264 BELGIUM HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 265 BELGIUM HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 266 BELGIUM HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 267 BELGIUM HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 268 REST OF EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19